![]() | Seaport West 155 Seaport Boulevard Boston, MA 02210-2600
617.832.1000 main 617.832.7000 fax | |
Hemmie Chang 617-832-1175 direct hchang@foleyhoag.com |
June 8, 2017
VIA EDGAR AND FEDERAL EXPRESS
Mr. Jim B. Rosenberg
Senior Assistant Chief Accountant
Office of Healthcare and Insurance
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re: | Applied Genetic Technologies Corporation |
Form 10-K for Fiscal Year Ended June 30, 2016
Filed September 12, 2016
File No. 001-36370
Dear Mr. Rosenberg:
I am writing on behalf of Applied Genetic Technologies Corporation (the “Company”) in response to additional comments presented to the Company telephonically by Jacob Luxenburg and Mary Mast of the staff (the “Staff”) of the Securities and Exchange Commission (the “SEC”) on May 22, 2017.
The Staff requested that, within ten business days, the Company provide a formal response to the additional comments delivered telephonically. On behalf the Company, I respectfully advise you that the Company anticipates that it will provide the requested response on or before June 16, 2017.
Please feel free to contact me at (617) 832-1175 if I can be of any assistance.
Sincerely, |
/s/ Hemmie Chang |
Hemmie Chang |
ATTORNEYS AT LAW | BOSTON | NEW YORK | PARIS | WASHINGTON | FOLEYHOAG.COM |
Mr. Jim B. Rosenberg
June 8, 2017
Page 2
cc: | Susan B. Washer, Applied Genetic Technologies Corporation |
Larry Bullock, Applied Genetic Technologies Corporation
Ann VanLent, Applied Genetic Technologies Corporation
Dan Clevenger, Foley Hoag, LLP